Open AccessBerberine Can Target the VEGFR2/ERK Pathway to Inhibit Angiogenesis in Glioblastoma Xenografts
Author(s) -
Huaze Liu
Publication year - 2022
Publication title -
proceedings of the 11th international conference on biomedical engineering and bioinformatics
Language(s) - English
Resource type - Conference proceedings
DOI - 10.5220/0011313500003443
Subject(s) - angiogenesis , berberine , mapk/erk pathway , vegf receptors , glioblastoma , cancer research , chemistry , medicine , signal transduction , pharmacology , microbiology and biotechnology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom